Researchers at UC San Diego used a multi-omics approach to investigate stool samples from patients with ulcerative colitis, a chronic inflammatory bowel disease. The team has identified the family of microbiome-derived enzymes driving the disease, and demonstrated a potential therapeutic solution.
Related Articles

News
Global Coronavirus Challenge Calls for U.S.-China Cooperation
April 9, 2020
sandiegobiotech
News, UCSD News
Comments Off on Global Coronavirus Challenge Calls for U.S.-China Cooperation
UC San Diego?s world-renowned scholars in U.S.-China studies explain what?s at stake.
[…]

News
Did Gonorrhea Give Us Grandparents?
UC San Diego researchers tracked the evolution of a gene variant that supports cognitive health in older humans, but may have first emerged to protect against bacteria.
[…]

News
New UC San Diego Health Study Addresses Loneliness in Patients with HIV
October 21, 2021
sandiegobiotech
News, UCSD News
Comments Off on New UC San Diego Health Study Addresses Loneliness in Patients with HIV
HIV is not what defines Candis Givens. In fact, very few people, including those close to her, know she has the virus. The effectiveness of new HIV treatments makes this possible for the San Diego resident. Unfo… […]